RMLHP Corporation
Programs
RML Specialty Hospital Care Programs
RMLHP CORPORATION ("RMLHP") MANAGES THE ACTIVITIES OF RML HEALTH PROVIDERS, LIMITED PARTNERSHIP D/B/A RML SPECIALTY HOSPITAL ("RML"), A RELATED IRC 501(C)(3) ORGANIZATION. RML OPERATES TWO LONG-TERM CARE HOSPITALS PROVIDING CERTAIN SPECIALTY SERVICES SUCH AS ACUTE VENTILATOR, REHABILITATION AND WOUND CARE. ALL PATIENT ADMISSIONS ARE REFERRED FROM OTHER AREA HOSPITALS FOR SPECIALTY CARE. IN THE MOST RECENT FISCAL YEAR (FY23), RML DELIVERED ON ITS MISSION TO PROVIDE QUALITY, COMPASSIONATE CARE TO PATIENTS FROM OUR REFERRING COMMUNITY WHO SUFFER FROM PROLONGED, SEVERE ILLNESS. OUR CARE PROGRAMS INCLUDED THE CARE AND WEANING OF PATIENTS WHO REQUIRE PROLONGED MECHANICAL VENTILATION, THE CARE AND TREATMENT OF PATIENTS WITH COMPLEX WOUNDS, AND THE CARE AND TREATMENT OF PATIENTS THAT REQUIRED PROLONGED ACUTE CARE HOSPITALIZATION. RML IS RECOGNIZED AS A LEADER IN LONG-TERM ACUTE CARE AND IS ONE OF THE LARGEST VENTILATOR WEANING HOSPITALS IN THE NATION. RML SERVED APPROXIMATELY 90 REFERRAL SOURCES THROUGHOUT THE CHICAGOLAND AREA, INCLUDING OUR PARTNER ORGANIZATIONS, MAJOR TERTIARY CARE CENTERS, AND COMMUNITY HOSPITALS. NEARLY 100% OF RML'S INPATIENT ADMISSIONS ARE DIRECT TRANSFERS FROM THESE HOSPITAL REFERRAL SOURCES. RML OPERATES A FACILITY LOCATED IN A LOW-INCOME AREA OF CHICAGO. OVER THE YEAR, WE HAVE MADE GREAT STRIDES IN IMPROVING OPERATIONS, STRENGTHENING THE VIABILITY OF AN ENTITY THAT PROVIDES QUALITY HEALTH CARE AND ADDITIONAL JOBS FOR THE INNER-CITY COMMUNITY. LONG-TERM ACUTE CARE WAS PROVIDED TO MORE THAN 1,250 PATIENTS BETWEEN BOTH RML FACILITIES, INCLUDING MORE THAN 540 MOSTLY MINORITY PATIENTS AT THE CHICAGO FACILITY. IN ORDER TO SUPPORT THE SPECIALIZED NEEDS OF OUR PATIENTS AND COMMUNITY, RML UTILIZES A PHYSICIAN-LED INTERDISCIPLINARY TEAM TO PROVIDE TREATMENT TO PATIENTS WITH ACUTE OR CATASTROPHIC ILLNESSES AND INJURIES COMPLICATED BY COMPLEX OR MULTIPLE CO-MORBIDITIES. OUR COMMITMENT TO EXCELLENCE AND SUPERIOR CLINICAL OUTCOMES HAS ALLOWED US TO IMPROVE ON OUR ALREADY-LOW HOSPITAL-ACQUIRED INFECTION AND PRESSURE ULCER RATES, AS WELL AS MAINTAIN A LOW RATE OF ADVERSE OUTCOMES (DEFINED AS EXPIRATIONS AND TRANSFERS TO ACUTE CARE HOSPITALS).GeographiesNot indicatedDatesJun 1, 2022 – May 31, 2023Source990No causes providedNo populations provided–$89.2K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)